Insider · CIK 0001949026
Decheng Capital Global Healthcare Fund (Master), LP
Files at ALPN (ALPINE IMMUNE SCIENCES, INC.). First filing Nov 14, 2023, latest Nov 14, 2023.
In brief
Decheng Capital Global Healthcare Fund (Master), LP files SEC Form 4 as 10% owner at ALPN (ALPINE IMMUNE SCIENCES, INC.). Since Nov 14, 2023, Decheng Capital Global Healthcare Fund (Master), LP has reported 1 open-market buy worth $4.7M and 0 open-market sells worth $0, the latest filed on Nov 14, 2023.
A track record needs three past buys with six months of prices behind them; Decheng Capital Global Healthcare Fund (Master), LP has 0, so none is measured yet.
The newest scored trade: bought $4.7M of ALPN on Nov 9, 2023, filed Nov 14, 2023, scored 46 (moderate).
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 46Moderate | ALPINE IMMUNE SCIENCES, INC. | $4.7M 375,000 shares | +28% | - |
Transactions
Every row this insider has filed, 1 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Nov 9, 2023 | ALPN ALPINE IMMUNE SCIENCES, INC. | POpen-market purchase Common Stock | +375,000 | $12.50 | $4.7M | 1,735,544 | Nov 14, 2023 |
Questions about Decheng Capital Global Healthcare Fund (Master), LP
Answered from the filings on this page, as of the latest one.
Is Decheng Capital Global Healthcare Fund (Master), LP buying or selling?
Not in the last 12 months. Decheng Capital Global Healthcare Fund (Master), LP's latest open-market trade on SEC Form 4 was bought $4.7M of ALPN on Nov 9, 2023.
How did Decheng Capital Global Healthcare Fund (Master), LP's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Decheng Capital Global Healthcare Fund (Master), LP has 0.
Where does Decheng Capital Global Healthcare Fund (Master), LP file Form 4?
Decheng Capital Global Healthcare Fund (Master), LP has filed Form 4 at ALPN (ALPINE IMMUNE SCIENCES, INC.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.